Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8211
-0.0757 (-8.44%)
At close: Sep 9, 2026, 4:00 PM EDT
0.8300
+0.0089 (1.08%)
After-hours: Sep 9, 2026, 6:35 PM EDT

Lucid Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
157143456053198
Market Cap Growth
12.32%214.80%-23.95%12.22%-73.09%-
Enterprise Value
147173996326197
Last Close Price
0.901.090.821.411.365.37

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
29.7530.3710.4524.58141.08395.33
PB Ratio
15.6613.078.42-25.832.313.61
P/TBV Ratio
14.97---2.713.61

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
28.0036.7922.7125.7968.61394.82

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.282.363.94-6.600.09-
Net Debt / Equity Ratio
-0.87-0.90-0.392.43-0.95-1.00
Net Debt / EBITDA Ratio
0.190.200.050.120.402.00
Net Debt / FCF Ratio
0.200.210.050.170.712.96
Asset Turnover
0.140.130.150.080.010.02
Inventory Turnover
13.4019.2222.9430.7411.970.88
Quick Ratio
1.291.271.010.712.8312.90
Current Ratio
1.331.311.070.752.8913.45
Return on Equity (ROE)
-556.27%-710.60%-2956.43%-507.97%-144.42%-136.23%
Return on Assets (ROA)
-81.63%-87.20%-99.28%-101.38%-76.84%-56.01%
Return on Capital Employed (ROCE)
-443.40%-418.40%-640.40%2295.50%-233.60%-50.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-40.13%-40.59%-100.30%-88.24%-105.61%-14.21%
FCF Yield
-29.13%-32.67%-97.89%-55.35%-57.52%-9.38%
Buyback Yield / Dilution
-103.51%-101.81%-20.98%-15.44%-94.44%-31.81%
SEC Filings: 10-K · 10-Q